Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
J Biol Chem ; 299(11): 105341, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37832873

ABSTRACT

The emergence of severe acute respiratory syndrome coronavirus 2, the causative agent of coronavirus disease 2019, has resulted in the largest pandemic in recent history. Current therapeutic strategies to mitigate this disease have focused on the development of vaccines and on drugs that inhibit the viral 3CL protease or RNA-dependent RNA polymerase enzymes. A less-explored and potentially complementary drug target is Nsp15, a uracil-specific RNA endonuclease that shields coronaviruses and other nidoviruses from mammalian innate immune defenses. Here, we perform a high-throughput screen of over 100,000 small molecules to identify Nsp15 inhibitors. We characterize the potency, mechanism, selectivity, and predicted binding mode of five lead compounds. We show that one of these, IPA-3, is an irreversible inhibitor that might act via covalent modification of Cys residues within Nsp15. Moreover, we demonstrate that three of these inhibitors (hexachlorophene, IPA-3, and CID5675221) block severe acute respiratory syndrome coronavirus 2 replication in cells at subtoxic doses. This study provides a pipeline for the identification of Nsp15 inhibitors and pinpoints lead compounds for further development against coronavirus disease 2019 and related coronavirus infections.


Subject(s)
Antiviral Agents , Endoribonucleases , SARS-CoV-2 , Viral Nonstructural Proteins , Antiviral Agents/pharmacology , Endoribonucleases/antagonists & inhibitors , SARS-CoV-2/drug effects , SARS-CoV-2/enzymology , Viral Nonstructural Proteins/antagonists & inhibitors , Virus Replication/drug effects
2.
Methods Mol Biol ; 2381: 227-242, 2021.
Article in English | MEDLINE | ID: mdl-34590280

ABSTRACT

In addition to advancing the development of gene-editing therapeutics, CRISPR/Cas9 is transforming how functional genetic studies are carried out in the lab. By increasing the ease with which genetic information can be inserted, deleted, or edited in cell and organism models, it facilitates genotype-phenotype analysis. Moreover, CRISPR/Cas9 has revolutionized the speed at which new genes underlying a particular phenotype can be identified through its application in genomic screens. Arrayed high-throughput and pooled lentiviral-based CRISPR/Cas9 screens have now been used in a wide variety of contexts, including the identification of essential genes, genes involved in cancer metastasis and tumor growth, and even genes involved in viral response. This technology has also been successfully used to identify drug targets and drug resistance mechanisms. Here, we provide a detailed protocol for performing a genome-wide pooled lentiviral CRISPR/Cas9 knockout screen to identify genetic modulators of a small-molecule drug. While we exemplify how to identify genes involved in resistance to a cytotoxic histone deacetylase inhibitor, Trichostatin A (TSA), the workflow we present can easily be adapted to different types of selections and other types of exogenous ligands or drugs.


Subject(s)
CRISPR-Cas Systems , CRISPR-Cas Systems/genetics , Drug Resistance , Gene Editing , Genome , Lentivirus , Pharmaceutical Preparations
3.
J Biol Chem ; 296: 100073, 2021.
Article in English | MEDLINE | ID: mdl-33187986

ABSTRACT

Tubby-like proteins (TULPs) are characterized by a conserved C-terminal domain that binds phosphoinositides. Collectively, mammalian TULP1-4 proteins play essential roles in intracellular transport, cell differentiation, signaling, and motility. Yet, little is known about how the function of these proteins is regulated in cells. Here, we present the protein-protein interaction network of TULP3, a protein that is responsible for the trafficking of G-protein-coupled receptors to cilia and whose aberrant expression is associated with severe developmental disorders and polycystic kidney disease. We identify several protein interaction nodes linked to TULP3 that include enzymes involved in acetylation and ubiquitination. We show that acetylation of two key lysine residues on TULP3 by p300 increases TULP3 protein abundance and that deacetylation of these sites by HDAC1 decreases protein levels. Furthermore, we show that one of these sites is ubiquitinated in the absence of acetylation and that acetylation inversely correlates with ubiquitination of TULP3. This mechanism is evidently conserved across species and is active in zebrafish during development. Finally, we identify this same regulatory module in TULP1, TULP2, and TULP4 and demonstrate that the stability of these proteins is similarly modulated by an acetylation switch. This study unveils a signaling pathway that links nuclear enzymes to ciliary membrane receptors via TULP3, describes a dynamic mechanism for the regulation of all tubby-like proteins, and explores how to exploit it pharmacologically using drugs.


Subject(s)
Eye Proteins/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , p300-CBP Transcription Factors/metabolism , Acetylation , Eye Proteins/genetics , HEK293 Cells , HeLa Cells , Histone Deacetylase 1/genetics , Histone Deacetylase 1/metabolism , Humans , Intracellular Signaling Peptides and Proteins/genetics , Protein Stability , p300-CBP Transcription Factors/genetics
4.
Cell Chem Biol ; 27(5): 475-478, 2020 05 21.
Article in English | MEDLINE | ID: mdl-32442413

ABSTRACT

In this issue of Cell Chemical Biology, Erdogan et al. (2020) describe a new CRISPR/Cas9-based strategy for performing directed evolution of mammalian proteins in situ. Using this technique to select functional mRuby3 variants within lysosomes, they identify mCRISPRed, a fluorescent protein that displays robust stability and activity at low pH.


Subject(s)
CRISPR-Cas Systems , Clustered Regularly Interspaced Short Palindromic Repeats , Animals , CRISPR-Cas Systems/genetics , Organelles
5.
Biochim Biophys Acta ; 1858(12): 3169-3181, 2016 12.
Article in English | MEDLINE | ID: mdl-27736635

ABSTRACT

Following intake and absorption of Cd into the bloodstream, one possible target is the lipid membrane surrounding erythrocytes as well as kidney and liver cells where Cd accumulates. We investigated the interactions of Cd with model membranes from a biophysical perspective by using fluorescence spectroscopy and dynamic light scattering to monitor changes in liposome size, membrane fluidity and lipid phase transition. The fluorescent probe Laurdan was incorporated into liposomes and used to quantitate cadmium induced fluidity changes in model systems hydrated in 20mM HEPES, 100mM NaCl pH7.4. The metal effects on membranes composed of the zwitterionic phosphatidylcholine were compared to the negatively charged lipids phosphatidic acid (PA), cardiolipin (CL), phosphatidylglycerol (PG), phosphatidylserine (PS) and phosphatidylinositol (PI). The data showed that 5-2000µM Cd electrostatically targeted negatively charged lipids and increased the rigidity of these membranes whereby the gel to liquid crystalline phase of fully saturated anionic lipids was increased following the order: PG>PS>CL~PA. In addition, dynamic light scattering showed that Cd induced liposome aggregation in all negatively charged systems except for the PGs. Moreover, both effects were much stronger for saturated acyl chains versus unsaturated species. Finally, charge localization was important as lipids carrying the charge more distant from the hydrophobic core of the bilayer showed stronger interactions with Cd.


Subject(s)
Cadmium/pharmacology , Liposomes/chemistry , Membrane Fluidity/drug effects , Phospholipids/chemistry , Edetic Acid/pharmacology , Lipid Bilayers/chemistry , Scattering, Radiation , Spectrometry, Fluorescence , Static Electricity
SELECTION OF CITATIONS
SEARCH DETAIL
...